Bacteriophages and cancer

Archives of Microbiology

Volumn 192, Issue 5, 2010, Pages 315-320

  Budynek, Paulina ^a   Dąbrowska, Krystyna ^a   Skaradziński, Grzegorz ^a   Górski, Andrzej ^a,b  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Bacteriophages; Cancer; Phage display

Indexed keywords

BETA3 INTEGRIN; GAMMA INTERFERON; GELATINASE A; GELATINASE B; INTERLEUKIN 2; SIALYL LEWIS X ANTIGEN; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR;

ANGIOGENESIS; ANTIBACTERIAL ACTIVITY; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; BACTERIAL INFECTION; BACTERIOPHAGE; BACTERIOPHAGE HAP1; BACTERIOPHAGE T4; CANCER CHEMOTHERAPY; CYTOKINE PRODUCTION; CYTOLYSIS; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; MACROPHAGE; MALIGNANT NEOPLASTIC DISEASE; PHAGE DISPLAY; PHAGOCYTOSIS; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE ACTIVATION; TUMOR REGRESSION;

BACTERIA (MICROORGANISMS); EUKARYOTA;

EID: 77952098438     PISSN: 03028933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00203-010-0559-7     Document Type: Short Survey

References (49)

1. W Arap R Pasqualini 1998 Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model Science 279 377 380 10.1126/science.279.5349. 377 1:CAS:528:DyaK1cXmtl2juw%3D%3D 9430587 (Pubitemid 28063372)
2. H Bar I Yacoby I Benhar 2008 Killing cancer cells by targeted drug-carrying phage nanomedicines BMC Biotechnol 8 37 10.1186/1472-6750-8-37 18387177 (Pubitemid 351566953)
3. R Binetruy-Tournaire C Demangel 2000 Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis EMBO J 19 1525 1533 10.1093/emboj/19.7.1525 1:CAS:528:DC%2BD3cXislymt74%3D 10747021
4. H Bloch 1940 Experimental investigation on the relationships between bacteriophages and malignant tumors Arch Virol 1 481 496 (in German)
5. J Boratyński D Syper B Weber-Dabrowska M Łusiak- Szelachowska G Poźniak A Górski 2004 Preparation of endotoxin-free bacteriophages Cell Mol Biol Lett 9 253 259 15213806
6. J Borysowski A Górski 2004 Phage display technology and its application to experimental oncological therapy (in Polish) Postepy Hig Med Dosw 58 100 107
7. K Dabrowska A Opolski J Wietrzyk K Switala-Jelen J Boratynski A Nasulewicz L Lipinska A Chybicka M Kujawa M Zabel B Dolinska-Krajewska E Piasecki B Weber-Dabrowska J Rybka J Salwa E Wojdat M Nowaczyk A Gorski 2004 Antitumour activity of bacteriophages in murine experimental cancer models caused possibly by inhibition of β3 integrin signaling pathway Acta Virol 48 241 248 1:CAS:528:DC%2BD2MXjsFaktbw%3D 15745047
8. K Dabrowska A Opolski J Wietrzyk K Switala-Jelen J Godlewska J Boratynski D Syper B Weber-Dabrowska A Gorski 2004 Anticancer activity of bacteriophage T4 and its mutant HAP1 in mouse experimental tumour models Anticancer Res 24 3991 3995 1:CAS:528:DC%2BD2MXitFylt74%3D 15736444
9. K Dabrowska K Switała-Jelen A Opolski B Weber-Dabrowska A Gorski 2005 Bacteriophage penetration in vertebrates J Appl Microbiol 98 7 13 10.1111/j.1365-2672.2004.02422.x 1:STN:280:DC%2BD2cnjsFSmtw%3D%3D 15610412 (Pubitemid 40139261)
10. K Da̧browska K Świtała-Jeleń A Opolski A Górski 2006 Possible association between phages, Hoc protein, and the immune system Arch Virol 151 209 215 10.1007/s00705-005-0641-7 16195787 (Pubitemid 43130582)
11. K Da̧browska M Zembala J Boratyński K Świtała- Jeleń J Wietrzyk A Opolski K Szczaurska M Kujawa J Godlewska A Górski 2007 Hoc protein regulates The biological effects of T4 phage in mammals Arch Microbiol 6 489 498 10.1007/s00203-007-0216-y (Pubitemid 46800698)
12. K Da̧browska G Skaradziński P Jończyk A Kurzȩpa J Wietrzyk B Owczarek M Zaczek K Świtała- Jeleń J Boratyński G Poźniak M Maciejewska A Górski 2009 The effect of bacteriophages T4 and HAP1 on in vitro melanoma migration BMC Microbiol 9 13 10.1186/1471-2180-9-13 19154575
13. M Di Giovine B Salone Y Martina V Amati G Zambruno E Cundari CM Failla I Saggio 2001 Binding properties, cell delivery, and gene transfer of adenoviral penton base displaying bacteriophage Virology 282 102 112 10.1006/viro.2000.0809 1:CAS:528:DC%2BD3MXhvFKjtbw%3D 11259194 (Pubitemid 32881779)
14. F Eriksson WD Culp R Massey L Egevad D Garland MAA Persson P Pisa 2007 Tumor specific phage particles promote tumor regression in a mouse melanoma model Cancer Immunol Immunother 56 677 687 10.1007/s00262-006-0227-6 16967280 (Pubitemid 46348740)
15. F Eriksson P Tsagozis K Lundeberg R Parsa SM Mangsbo MAA Persson RA Harris P Pisa 2009 Tumor-specific bacteriophages induce tumor destruction through activation of tumor-associated macrophages J Immunol 182 3105 3111 10.4049/jimmunol.0800224 1:CAS:528:DC%2BD1MXitFKgsr0%3D 19234207
16. I Fogelman V Davey HD Ochs M Elashoff MB Feinberg J Mican JP Siegel M Sneller HC Lane 2000 Evaluation of CD4+ T cell function in vivo in HIV-infected patients as measured by bacteriophage phiX174 immunization J Infect Dis 182 435 441 10.1086/315739 1:CAS:528:DC%2BD3cXmvVWgsr0%3D 10915073 (Pubitemid 30651039)
17. A Fokine PR Chipman PG Leiman VV Mesyanzhinov VB Rao MG Rossmann 2004 Molecular architecture of the prolate head of bacteriophage T4 Proc Natl Acad Sci U S A 101 6003 6008 10.1073/pnas.0400444101 1:CAS:528:DC%2BD2cXjsFKnsb4%3D 15071181 (Pubitemid 38520518)
18. MN Fukuda C Ohyama 2000 A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells Cancer Res 60 450 456 1:CAS:528:DC%2BD3cXhtVahsbg%3D 10667600
19. A Gorski B Weber-Dabrowska 2005 The potential role of endogenous bacteriophages in controlling invading pathogens Cell Mol Life Sci 62 511 519 10.1007/s00018-004-4403-6 1:CAS:528:DC%2BD2MXksVags7o%3D 15747058 (Pubitemid 40386333)
20. A Gorski K Dabrowska K Switala-Jelen M Nowaczyk B Weber-Dabrowska J Boratynski J Wietrzyk A Opolski 2003 New insights into the possible role of bacteriophages in host defence and disease Med Immunol 2 2 10.1186/1476-9433-2-2 12625836 (Pubitemid 38751428)
21. Gorski A, Borysowski J, Miedzybrodzki R, Weber-Dabrowska B (2007) Bacteriophages in medicine. In: Mc Grath S (ed) Bacteriophage genetics and molecular biology. Caister Academic Press, Norfolk, p 125
22. A Górski E Wazna B Weber-Dabrowska K Dabrowska K Switała-Jeleń R Miedzybrodzki 2006 Bacteriophage translocation FEMS Immunol Med Microbiol 46 313 319 10.1111/j.1574-695X.2006.00044.x 16553803
23. L Hetian A Ping 2002 A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor J Biol Chem 277 43137 43142 10.1074/jbc.M203103200 12183450 (Pubitemid 35285698)
24. M Kantoch M Mordarski 1958 Binding of bacterial viruses by cancer cells in vitro Postepy Hig Med Dosw 12 191 192 1:STN:280:DyaG1M%2FjtVOqtQ%3D%3D 13601395
25. E Kelly SJ Russell 2007 History of oncolytic viruses: genesis to genetic engineering Mol Ther 15 651 659 10.1038/sj.mt.6300033 1:CAS:528: DC%2BD2sXhtVejtb7F 17299401 (Pubitemid 46043667)
26. E Koivunen W Arap 1999 Tumor targeting with a selective gelatinase inhibitor Nat Biotechmol 17 768 774 10.1038/11703 1:CAS:528:DyaK1MXmtFaiurc%3D (Pubitemid 29365104)
27. A Kucharewicz-Krukowska S Slopek 1987 Immunogenic effect of bacteriophage in patients subjected to phage therapy Arch Immunol Ther Exp (Warsz.) 35 553 561 1:STN:280:DyaL1czjvFGhtQ%3D%3D
28. Kutter E (1997) Phage therapy: bacteriophages as antibiotics, http://www.evergreen.edu/phage/phagetherapy/phagetherapy.html
29. PG Leiman S Kanamaru VV Mesyanzhinov F Arisaka MG Rossmann 2003 Structure and morphogenesis of bacteriophage T4 Cell Mol Life Sci 60 2356 2370 10.1007/s00018-003-3072-1 1:CAS:528:DC%2BD2cXjvFelsrg%3D 14625682 (Pubitemid 37487257)
30. XB Li HJ Schluesener SQ Xu 2006 Molecular addresses of tumors: selection by in vivo phage display Arch Immunol Ther Exp (Warsz) 54 3 177 181 10.1007/s00005-006-0026-y 1:CAS:528:DC%2BD28Xot1Cgurs%3D (Pubitemid 44257338)
31. A Lorch 1999 Bacteriophages: an alternative to antibiotics? Biotechnol Dev Monit 39 14 17 (Pubitemid 129634985)
32. Miȩdzybrodzki R, Fortuna W, Weber-Da̧browska B, Górski A (2009) A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses. Clin Exp Med. doi: 10.1007/s10238-009-0044-2
33. J Newton SL Deutscher 2008 Phage peptide display Handb Exp Pharmacol 185 Pt 2 145 163 10.1007/978-3-540-77496-9-7 1:CAS:528:DC%2BD1MXhs1Wiu7Y%3D 18626602
34. F Nilsson H Kosmehl 2001 Targeted delivery of tissue factor to the ED-B domain of fibronectin mediates the infarction of solid tumors in mice Cancer Res 61 711 716 1:CAS:528:DC%2BD3MXht1Gmtrg%3D 11212273
35. E Pajtasz-Piasecka J Rossowska D Duś B Weber-Dabrowska A Zablocka A Gorski 2008 Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma Immunol Lett 116 24 32 10.1016/j.imlet.2007.11.004 1:CAS:528:DC%2BD1cXhtl2isr8%3D 18166233
36. A Przerwa M Zimecki K Switała-Jeleń K Dabrowska E Krawczyk M Łuczak B Weber-Dabrowska D Syper R Miedzybrodzki A Górski 2006 Effects of bacteriophages on free radical production and phagocytic functions Med Microbiol Immunol 195 143 150 10.1007/s00430-006-0011-4 1:CAS:528: DC%2BD28XnslSjtrs%3D 16447074 (Pubitemid 44421174)
37. J Qiu P Luo K Wasmund Z Steplewski T Kieber-Emmons 1999 Towards the development of peptide mimotopes of carbohydrate antigens as cancer vaccines Hybridoma 18 1 103 112 10.1089/hyb.1999.18.103 1:CAS:528:DyaK1MXit1ahsLY%3D 10211797
38. A Ribas LH Butterfield JS Economou 2000 Genetic immunotherapy for cancer Oncologist 5 87 98 10.1634/theoncologist.5-2-87 1:CAS:528:DC%2BD3cXjs1Wnu7s%3D 10794799
39. WT Shearer DJ Lugg HM Rosenblatt PM Nickoll RM Sharp JM Reuben HD Ochs 2001 Antibody responses to bacteriophage phiX174 in human subjects exposed to the antarctic wind-over model of spaceflight J Allergy Clin Immunol 107 19 20 10.1067/mai.2001.112034 (Pubitemid 32105237)
40. JG Sinkovics JC Horvath 2008 Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers Arch Immunol Ther Exp (Warsz) 56 Suppl 1 3s 59s
41. GP Smith 1985 Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface Science 228 1315 1316 10.1126/science.4001944 1:STN:280:DyaL2M3hvVOquw%3D%3D 4001944
42. Szczaurska-Nowak K (2009) Badanie mechanizmu działania przeciwnowotworowego preparatu fagowego BP T4 u myszy obarczonych przeszczepialnym czerniakiem B16 (In Polish). Dissertation, Polish Academy of Science, Institute of Immunology and Experimental Therapy, Wroclaw, Poland
43. Tallant C, Marrero A, Gomis-Rüth FX (2009) Matrix metalloproteinases. Fold and function of their catalytic domains. Biochim Biophys Acta. doi: 10.1016/j.bbamcr.2009.04.003
44. F Uchiyama Y Tanaka Y Minari N Tokui 2005 Designing scaffolds of peptides for phages display libraries J Biosci Bioeng 99 5 448 456 10.1263/jbb.99.448 1:CAS:528:DC%2BD2MXmtlCjs7o%3D 16233816 (Pubitemid 40874522)
45. A Vitaliti M Wittmer 2002 Inhibition of tumor angiogenesis by a single-chain antibody directed against vascular growth factor Cancer Res 60 4311 4314
46. B Weber-Dabrowska M Mulczyk A Gorski 2001 Therapy of infections in cancer patients with bacteriophages Clin Appl Immunol Rev 1 131 10.1016/S1529-1049(01) 00015-0
47. Y Woo PS Adusumilli Y Fong 2006 Advances in oncolytic viral therapy Curr Opin Investig Drugs 7 549 559 1:CAS:528:DC%2BD28XmsFyqtbc%3D 16784026
48. World Health Organization (2002) WHO health topics, antimicrobial resistance (fact sheet 194, Jan 2002). http://www.who.int/topics/en/
49. World Health Organization (2005) World alliance for patient safety "WHO Guidelines on hand hygiene in health care (advanced draft): a summary". http://www.who.int/patientsafety/events/05/HH-en.pdf